Transforming Growth Factor β Stabilizes p15^INK4B Protein, Increases p15^INK4B-cdk4 Complexes, and Inhibits Cyclin D1-cdk4 Association in Human Mammary Epithelial Cells

REFERENCES

• Bates, S., D. Parry, L. Bonetta, K. Vousden, C. Dickson, and G. Peters. 1994. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9:1633–1640.
   PubMed Web of Science ®Google Scholar
• Brenner, A. J., and C. M. Aldaz. 1995. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res. 55:2892–2895.
   PubMedGoogle Scholar
• Chan, F. K. M., J. Zhang, L. Cheng, D. N. Shapiro, and A. Winoto. 1995. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Mol. Cell. Biol. 15:2682–2688.
   PubMed Web of Science ®Google Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. Macdonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294–5299.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545–5549.
   PubMed Web of Science ®Google Scholar
• Dulic, V., W. K. Kaufman, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013–1023.
   PubMed Web of Science ®Google Scholar
• Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958–1961.
   PubMed Web of Science ®Google Scholar
• Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, R. C. Bast, Jr., J. D. Iglehart, and J. R. Marks. 1994. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1301–1307.
   PubMedGoogle Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor supression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Enders, G. H., J. Koh, A. K. Rustigi, C. Missero, and E. Harlow. 1995. p16 inhibition of transformed and primary squamous epithelial cells. Oncogene 12:1239–1245.
   Google Scholar
• Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009–1020.
   PubMed Web of Science ®Google Scholar
• Florenes, V. A., N. Bhattacharya, M. R. Bani, J. Ben-David, R. S. Kerbel, and J. M. Slingerland. 1996. TGF-β mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1 and p27Kip1. Oncogene, 13:2447–2457.
   PubMedGoogle Scholar
• Flores-Rosas, H., Z. Kelman, F. B. Dean, Z. Pan, J. W. Harper, S. J. Elledge, M. O’Donnell, and J. Hurwitz. 1994. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase S holoenzyme. Proc. Natl. Acad. Sci. USA 91:8655–8659.
   PubMedGoogle Scholar
• Fynan, T. M., and M. Reiss. 1993. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis. Crit. Rev. On-cog. 4:493–540.
   Google Scholar
• Geng, Y., and R. A. Weinberg. 1993. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90:10315–10319.
   PubMed Web of Science ®Google Scholar
• Guan, K.-L., C. W. Jenkins, Y. Li, M. A. Nichols, Y. Wu, C. L. O’Keefe, A. G. Matera, and Y. Xiong. 1994. Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:2939–2952.
   PubMed Web of Science ®Google Scholar
• Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018–1022.
   PubMed Web of Science ®Google Scholar
• Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581–1588.
   PubMed Web of Science ®Google Scholar
• Hammond, S. L., R. G. Ham, and M. R. Stampfer. 1984. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl. Acad. Sci. USA 81:5435–5439.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-p-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., S. Elledge, K. Keyomarsi, B. Dynlacht, L.-H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387–400.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543–546.
   PubMed Web of Science ®Google Scholar
• Hengst, L., V. Dulic, J. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle regulated inhibitor of cyclin dependent kinases. Proc. Natl. Acad. Sci. USA 91:5291–5294.
   PubMed Web of Science ®Google Scholar
• Hengst, L., and S. Reed. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861–1864.
   PubMed Web of Science ®Google Scholar
• Hirai, H., M. F. Roussel, J.-Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672–2681.
   PubMed Web of Science ®Google Scholar
• Hosobuchi, M., and M. Stampfer. 1989. Effects of the transforming growth factor |3 on growth of human mammary epithelial cells in culture. In Vitro Cell. Dev. Biol. 25:705–713.
   PubMedGoogle Scholar
• Iavarone, A., and J. Massague. Personal communication.
   Google Scholar
• Kamb, A., N. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tav-tigian, E. Stockert, R. Day III, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436–440.
   PubMed Web of Science ®Google Scholar
• Kerbel, R. S. 1992. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer: malignant melanoma as a paradigm. Am. J. Pathol. 141:519–524.
   PubMed Web of Science ®Google Scholar
• Ko, T. C., H. M. Sheng, D. Reisman, E. A. Thompson, and R. D. Beauchamp. 1995. Transforming growth factor-p1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10:177–184.
   PubMed Web of Science ®Google Scholar
• Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-depen-dent kinase by TGF-β. Science 260:536–539.
   PubMed Web of Science ®Google Scholar
• LaBaer, J., M. Garrett, L. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. New functional activities for the p21 family of CDK inhibitors. Genes Dev., in press.
   Google Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-p1 linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185.
   PubMed Web of Science ®Google Scholar
• Lee, M.-H., I. Reynisdottir, and J. Massague. 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with a unique domain structure and tissue distribution. Genes Dev. 9:639–649.
   PubMed Web of Science ®Google Scholar
• Li, R., S. Waga, G. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534–537.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. W. Jenkins, M. A. Nichols, and X. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent inhibitor p21. Oncogene 9:2261–2268.
   PubMed Web of Science ®Google Scholar
• Lukas, J., J. Bartkova, M. Rohde, M. Strauss, and J. Bartek. 1995. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600–2611.
   PubMed Web of Science ®Google Scholar
• Lukas, J., D. Parry, L. Aagaard, D. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375:503–506.
   PubMed Web of Science ®Google Scholar
• Massague, J., S. Cheifetz, M. Laiho, D. A. Ralph, F. M. B. Weis, and A. Zentella. 1992. Transforming growth factor-β. Cancer Surv. 12:81–103.
   PubMedGoogle Scholar
• Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. Zhang, A. Baldini, J. W. Harper, and S. J. Elledge. 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650–662.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of Cdk regulation. Nature 374:131–134.
   PubMed Web of Science ®Google Scholar
• Murray, A. W. 1992. Creative blocks: cell cycle checkpoints and feedback controls. Nature 359:599–604.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and K. Nakayama. 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720.
   PubMed Web of Science ®Google Scholar
• Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90–98.
   PubMed Web of Science ®Google Scholar
• Norbury, C., and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441–470.
   PubMed Web of Science ®Google Scholar
• Okamoto, A., S. P. Hussain, K. Hagiwara, E. A. Spillare, M. R. Rusin, D. J. Demetrick, M. Serrano, G. J. Hannon, M. Shiseki, M. Zariwala, Y. Xiong, D. H. Beach, J. Yokota, and C. C. Harris. 1995. Mutations in the p16INK4/ MTS1/CDKN2, p14INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 55:1448–1451.
   PubMed Web of Science ®Google Scholar
• Otsuki, T., H. M. Clark, A. Wellmann, E. S. Jaffe, and M. Raffeld. 1995. Involvement of CDKN2 (p16INK4A/MRS1) and p15INK4B/MTS2 in human leukemias and lymphomas. Cancer Res. 55:1436–1440.
   PubMed Web of Science ®Google Scholar
• Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685.
   PubMed Web of Science ®Google Scholar
• Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E. N. Olsen, J. W. Harper, and S. J. Elledge. 1995. p53-independent expression of p21CIP1 in muscle and other terminally differentiating cells. Science 267:1024–1028.
   PubMed Web of Science ®Google Scholar
• Parry, D., S. Bates, D. J. Mann, and G. Peters. 1995. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14:503–511.
   PubMed Web of Science ®Google Scholar
• Peters, G. 1994. Stifled by inhibitors. Nature 371:204–205.
   PubMedGoogle Scholar
• Petrocelli, T., R. Poon, D. Drucker, J. Slingerland, and C. Rosen. 1996. UVB irradiation induces p21Cip1/WAF1 and mediates G1 and S phase checkpoints. Oncogene 12:1387–1396.
   PubMed Web of Science ®Google Scholar
• Pierce, D. F. J., M. D. Johnson, Y. Matzui, S. D. Robinson, L. I. Gold, A. F. Purchio, C. W. Daniel, B. L. M. Hogan, and H. Moses. 1993. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes Dev. 7:2308–2317.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses. 1990. TGFβ1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, J. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27KIP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-p and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Poon, R., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet light. Mol. Biol. Cell 6:1197–1213.
   PubMed Web of Science ®Google Scholar
• Reed, S. I., E. Bailly, V. Dulic, L. Hengst, D. Resnitzky, and J. Slingerland. 1994. G1 control in mammalian cells. J. Cell Sci. Suppl. 18:69–73.
   PubMedGoogle Scholar
• Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-p. Genes Dev. 9:1831–1845.
   PubMed Web of Science ®Google Scholar
• Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/Cdk4. Nature 366:704–707.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Silberstein, G. B., and C. W. Daniel. 1987. Reversible inhibition of mammary gland growth by transforming growth factor-β. Science 237:291–293.
   PubMedGoogle Scholar
• Skapek, S. X., J. Rhee, D. B. Spicer, and D. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022–1024.
   PubMed Web of Science ®Google Scholar
• Slingerland, J. M., L. Hengst, C.-H. Pan, D. Alexander, M. R. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14:3683–3694.
   PubMed Web of Science ®Google Scholar
• Solomon, M. J. 1993. Activation of the various cyclin/cdc2 protein kinases. Curr. Opin. Cell Biol. 5:180–186.
   PubMed Web of Science ®Google Scholar
• Stampfer, M. 1985. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9:107–115.
   Google Scholar
• Stampfer, M. R., and J. C. Bartley. 1985. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA 82:2392–2398.
   Google Scholar
• Stampfer, M. R., C.-H. Pan, J. Hosoda, J. Bartholomew, J. Mendelsohn, and P. Yaswen. 1993. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous re-entry into the cell cycle. Exp. Cell Res. 208:175–188.
   PubMedGoogle Scholar
• Stampfer, M. R., and J. M. Slingerland. Unpublished results.
   Google Scholar
• Stampfer, M. R., P. Yaswen, M. Alhadeff, and J. Hosoda. 1993. TGF-β induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J. Cell. Physiol. 155:210–221.
   PubMedGoogle Scholar
• Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67–74.
   PubMed Web of Science ®Google Scholar
• Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574–578.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704.
   PubMed Web of Science ®Google Scholar
• Zhang, H., G. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750–1758.
   PubMed Web of Science ®Google Scholar